Black Rock Inc. Windtree Therapeutics Inc Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $1.14 $18,490 - $55,472	-48,660 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.94 - $1.6 $2,216 - $3,772	-2,358 Reduced 4.62%	48,660 $56,000
Q4 2021 Feb 10, 2022	BUY	$1.4 - $2.31 $1,833 - $3,026	1,310 Added 2.64%	51,018 $82,000
Q3 2021 Nov 09, 2021	SELL	$1.66 - $2.27 $13,027 - $17,814	-7,848 Reduced 13.64%	49,708 $102,000
Q2 2021 Aug 11, 2021	BUY	$1.68 - $2.79 $96,694 - $160,581	57,556 New	57,556 $132,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.